홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

N-(2-chloroethyl)-2-methyl-3-hydroxy-4-pyridinone → N-(4-propargylpiperazin-1-ylethyl)-2-methyl-3-hydroxy-4-pyridinone

HRID 557253
인쇄

반응식

HRID 557253 반응식
Cl[CH2:2][CH2:3][N:4]1[CH:9]=[CH:8][C:7](=[O:10])[C:6]([OH:11])=[C:5]1[CH3:12].[CH2:13]([N:16]1[CH2:21][CH2:20][NH:19][CH2:18][CH2:17]1)[C:14]#[CH:15]>>[CH2:13]([N:16]1[CH2:21][CH2:20][N:19]([CH2:2][CH2:3][N:4]2[CH:9]=[CH:8][C:7](=[O:10])[C:6]([OH:11])=[C:5]2[CH3:12])[CH2:18][CH2:17]1)[C:14]#[CH:15]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 337279N-(2-chloroethyl)-2-methyl-3-hydroxy-4-pyridinoneHCID 146273691-(2-Propynyl)piperazine

생성물 1

HCID 58730241N-(4-propargylpiperazin-1-ylethyl)-2-methyl-3-hydroxy-4-pyridinone

실험 절차

The title compound was prepared as described in Scheme D by reaction of N-(2-chloroethyl)-2-methyl-3-hydroxy-4-pyridinone (H2, Appendix VII) (prepared as described in Bijaya L. Rai, Lotfollah Dekhordi, Hicham Khodr, Yi Jin, Zudong Liu, and Robert C. Hider J. Med. Chem. 1998, 41,3347-3359) with N-propargylpiperazine (obtained as in step (iii) in Example 2):

출처 및 근거

ORD 기록
ord-194915e88a1a4046b094fe8c00e075a1
출처 데이터셋
uspto-grants-2011_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08058442B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트